Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Messina

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Advances in Anatomic Pathology|December 10, 2015
Update on Thin Melanoma: Outcome of an International WorkshopDaniela Mihic-Probst, Chris Shea, Lyn Duncan, et al.
The American Journal of Dermatopathology|February 25, 2016
Cellular Blue Nevomelanocytic Lesions: Analysis of Clinical, Histological, and Outcome Data in 37 CasesTawny Hung, Zsolt Argenyi, Lori Erickson, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 25, 2007
Phase II trial of B7-1 (CD-86) transduced, cultured autologous tumor cell vaccine plus subcutaneous interleukin-2 for treatment of stage IV renal cell carcinomaMayer Fishman, Terri B Hunter, Hatem Soliman, et al.
Leukemia & Lymphoma|September 1, 2021
Clinical characteristics and prognostic factors of 70 patients with Sézary syndrome: a single-institutional experience at Moffitt cancer centerYumeng Zhang, Lucia Seminario-Vidal, Christa Varnadoe, et al.
The American Journal of Surgical Pathology|December 29, 2007
Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus")Raymond L Barnhill, Zsolt Argenyi, Marianne Berwick, et al.
Pigment Cell & Melanoma Research|August 8, 2009
Meeting report: consensus from the first and second Global Workshops in Melanoma November 19-20, 2008Sanjiv S Agarwala, Jurgen C Becker, Alexander M Eggermont, et al.
Journal of Cutaneous Pathology|March 3, 2015
Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanomaLoren E Clarke, M B Warf, Darl D Flake, et al.
Journal for Immunotherapy of Cancer|November 13, 2024
Differences in the pathological, transcriptomic, and prognostic implications of lymphoid structures between primary and metastatic cutaneous melanomasLilit Karapetyan, Aofei Li, Danielle Vargas De Stefano, et al.
Nature|January 11, 2018
High response rate to PD-1 blockade in desmoplastic melanomasZeynep Eroglu, Jesse M Zaretsky, Siwen Hu-Lieskovan, et al.
Scientific Reports|February 3, 2021
Automated digital TIL analysis (ADTA) adds prognostic value to standard assessment of depth and ulceration in primary melanomaMichael R Moore, Isabel D Friesner, Emanuelle M Rizk, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Advances in Anatomic Pathology|December 10, 2015
Update on Thin Melanoma: Outcome of an International WorkshopDaniela Mihic-Probst, Chris Shea, Lyn Duncan, et al.
The American Journal of Dermatopathology|February 25, 2016
Cellular Blue Nevomelanocytic Lesions: Analysis of Clinical, Histological, and Outcome Data in 37 CasesTawny Hung, Zsolt Argenyi, Lori Erickson, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 25, 2007
Phase II trial of B7-1 (CD-86) transduced, cultured autologous tumor cell vaccine plus subcutaneous interleukin-2 for treatment of stage IV renal cell carcinomaMayer Fishman, Terri B Hunter, Hatem Soliman, et al.
Leukemia & Lymphoma|September 1, 2021
Clinical characteristics and prognostic factors of 70 patients with Sézary syndrome: a single-institutional experience at Moffitt cancer centerYumeng Zhang, Lucia Seminario-Vidal, Christa Varnadoe, et al.
The American Journal of Surgical Pathology|December 29, 2007
Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus")Raymond L Barnhill, Zsolt Argenyi, Marianne Berwick, et al.
Pigment Cell & Melanoma Research|August 8, 2009
Meeting report: consensus from the first and second Global Workshops in Melanoma November 19-20, 2008Sanjiv S Agarwala, Jurgen C Becker, Alexander M Eggermont, et al.
Journal of Cutaneous Pathology|March 3, 2015
Clinical validation of a gene expression signature that differentiates benign nevi from malignant melanomaLoren E Clarke, M B Warf, Darl D Flake, et al.
Journal for Immunotherapy of Cancer|November 13, 2024
Differences in the pathological, transcriptomic, and prognostic implications of lymphoid structures between primary and metastatic cutaneous melanomasLilit Karapetyan, Aofei Li, Danielle Vargas De Stefano, et al.
Nature|January 11, 2018
High response rate to PD-1 blockade in desmoplastic melanomasZeynep Eroglu, Jesse M Zaretsky, Siwen Hu-Lieskovan, et al.
Scientific Reports|February 3, 2021
Automated digital TIL analysis (ADTA) adds prognostic value to standard assessment of depth and ulceration in primary melanomaMichael R Moore, Isabel D Friesner, Emanuelle M Rizk, et al.
Pageof 7